Evidence map›Paper›PMID 38052876›Full record

ArticleScientific reports2023

Chlamydophila pneumoniae-associated community-acquired pneumonia in paediatric patients of a tertiary care hospital in Mexico: molecular diagnostic and clinical insights.

Jocelin Merida Vieyra, Agustín De Colsa Ranero, Deborah Palacios Reyes, Chiharu Murata, Alejandra Aquino Andrade

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Infection and immunity · 2026
    Article
  3. Risk factors for severeFrontiers in pediatrics · 2026
    Article
  4. Article
  5. Characteristics ofFrontiers in pediatrics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jocelin Merida VieyraLaboratory of Molecular Microbiology, Instituto Nacional de Pediatria, Insurgentes Sur 3700C, Insurgentes Cuicuilco, Coyoacan, 04530, Mexico City, Mexico.
Agustín De Colsa RaneroDepartment of Paediatric Infectious Diseases, Instituto Nacional de Pediatria, Mexico City, Mexico.
Deborah Palacios ReyesDepartment of Paediatric Infectious Diseases, Instituto Nacional de Pediatria, Mexico City, Mexico.
Chiharu MurataDepartment of Research Methodology, Instituto Nacional de Pediatria, Mexico City, Mexico.
Alejandra Aquino AndradeLaboratory of Molecular Microbiology, Instituto Nacional de Pediatria, Insurgentes Sur 3700C, Insurgentes Cuicuilco, Coyoacan, 04530, Mexico City, Mexico. aaquinoa@pediatria.gob.mx.
Instituto Nacional de Pediatria · MX

Funding

Fiscal Resources Modality A of the National Institute of Paediatrics 2015 2015Instituto Cientifico Pfizer (Fondo de Investigación Epidemiologica 2014) 2014
6 · The paper itself

Abstract

Chlamydophila pneumoniae is a cause of community-acquired pneumonia (CAP) and responsible for 1-2% of cases in paediatric patients. In Mexico, information on this microorganism is limited. The aim of this study was to detect C. pneumoniae using two genomic targets in a real-time PCR and IgM/IgG serology assays in paediatric patients with CAP at a tertiary care hospital in Mexico City and to describe their clinical characteristics, radiological features, and outcomes. A total of 154 hospitalized patients with diagnosis of CAP were included. Detection of C. pneumoniae was performed by real-time PCR of the pst and arg genes. Complete blood cell count, C-reactive protein measurement and IgM and IgG detection were performed. Clinical-epidemiological and radiological data from the patients were collected. C. pneumoniae was detected in 25 patients (16%), of whom 88% had underlying disease (P = 0.014). Forty-eight percent of the cases occurred in spring, 36% in girls, and 40% in children older than 6 years. All patients had cough, and 88% had fever. Interstitial pattern on chest-X-ray was the most frequent (68%), consolidation was observed in 32% (P = 0.002). IgM was positive in 7% and IgG in 28.6%. Thirty-six percent presented complications. Four percent died. A high proportion showed co-infection with Mycoplasma pneumoniae (64%). This is the first clinical report of C. pneumoniae as a cause of CAP in Mexican paediatric patients, using two genomic target strategy and serology. We found a frequency of 16.2% with predominance in children under 6 years of age. In addition; cough and fever were the most common symptoms. Early detection of this pathogen allows timely initiation of specific antimicrobial therapy to reduce development of complications. This study is one of the few to describe the presence of C. pneumoniae in patients with underlying diseases.

Indexed as

Chlamydophila pneumoniaeCommunity-Acquired InfectionsPneumonia, MycoplasmaChildChild, PreschoolCoughFemaleHumansImmunoglobulin GImmunoglobulin MMexicoMycoplasma pneumoniaePathology, MolecularTertiary Care CentersImmunoglobulin GImmunoglobulin M

Identifiers

PMID38052876
PMCPMC10698025
OpenAlexW4389378124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.